Short-term clinical efficacy of 125I radioactive seeds implantation in treating the postoperative lung metastases of malignant fibrous histiocytoma / 中国综合临床
Clinical Medicine of China
; (12): 1191-1193, 2012.
Article
em Zh
| WPRIM
| ID: wpr-428162
Biblioteca responsável:
WPRO
ABSTRACT
Objective To investigate the short-term clinical efficacy of CT-guided percutaneous implantation of 125I radioactive seeds in treating the postoperative lung metastases of malignant fibrous histiocytoma(MFH).Methods Eight patients with lung metastases after MFH surgery received CT-guided percutaneous implantation of 125I radioactive seeds.There are 28 metastasis lesions in total.Prescribed dose (PD) was 80 Gy and radioactivity was 0.7 mCi(2.59 × 107 Bq).Six months after implantation,chest CT-scan was performed and the changes were reviewed according to the international standards.ResultsAverage dose received by tumor was ( 172.9 ± 39.9 ) Gy,D100 ( 77.7 ± 10.2 ) Gy and D90 ( 97.2 ± 6.8 ) Gy.The overall response rate was 82.1%.Patients' survival period was 10.0 - 26.0 ( 14.6 ± 3.5 ) months with the median survival time of 13 months.ConclusionIn the treatment of postoperative lung metastases of MFH,implantation of 125I radioactive seeds produces a good short-term clinical efficacy.
Texto completo:
1
Índice:
WPRIM
Tipo de estudo:
Guideline
Idioma:
Zh
Revista:
Clinical Medicine of China
Ano de publicação:
2012
Tipo de documento:
Article